4//SEC Filing
CROOKE STANLEY T 4
Accession 0000874015-20-000172
CIK 0000874015other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 7:42 PM ET
Size
7.8 KB
Accession
0000874015-20-000172
Insider Transaction Report
Form 4
CROOKE STANLEY T
DirectorChairman, President, CEO
Transactions
- Sale
Common Stock
2020-12-15$49.77/sh−39,000$1,941,225→ 600,391 total(indirect: By Trust) - Sale
Common Stock
2020-12-17$50.50/sh−1,407$71,054→ 174 total(indirect: By Spouse)
Holdings
- 2,021
Common Stock
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 2, 2020.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.50 to $50.00, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.
- [F3]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person's wife on January 2, 2020.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0000897667
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 7:42 PM ET
- Size
- 7.8 KB